Clinical Cancer Research: 25 (24)

Highlights

Highlights

Highlights of This Issue

Clin Cancer Res December 15 2019 25 (24) 7267-7267;

CCR Translations

CCR Translations

A New Pathway Emerges to Interpret Lung Cancer Genomic Alterations

Collin M. Blakely

Clin Cancer Res December 15 2019 25 (24) 7269-7271; DOI:10.1158/1078-0432.CCR-19-2861
CCR Translations

Mogamulizumab Forecast: Clearer Patients, with a Slight Chance of Immune Mayhem

Cecilia Larocca, Thomas S. Kupper and Nicole R. LeBoeuf

Clin Cancer Res December 15 2019 25 (24) 7272-7274; DOI:10.1158/1078-0432.CCR-19-2742

CCR Drug Updates

CCR Drug Updates

FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome

Yvette L. Kasamon, Haiyan Chen, R. Angelo de Claro, Lei Nie, Jingjing Ye, Gideon M. Blumenthal, Ann T. Farrell and Richard Pazdur

Clin Cancer Res December 15 2019 25 (24) 7275-7280; DOI:10.1158/1078-0432.CCR-19-2030

Perspectives

Perspectives

Lessons Learned from Deescalation Trials in Favorable Risk HPV-Associated Squamous Cell Head and Neck Cancer–A Perspective on Future Trial Designs

Steffen Ventz, Lorenzo Trippa and Jonathan D. Schoenfeld

Clin Cancer Res December 15 2019 25 (24) 7281-7286; DOI:10.1158/1078-0432.CCR-19-0945

Clinical Trials: Targeted Therapy

Clinical Trials: Targeted Therapy

Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors

César Serrano, Alessandro Leal, Yanan Kuang, Jeffrey A. Morgan, Constance M. Barysauskas, Jillian Phallen, Olivia Triplett, Adrián Mariño-Enríquez, Andrew J. Wagner, George D. Demetri, Victor E. Velculescu, Cloud P. Paweletz, Jonathan A. Fletcher and Suzanne George

Clin Cancer Res December 15 2019 25 (24) 7287-7293; DOI:10.1158/1078-0432.CCR-19-2150
Clinical Trials: Targeted Therapy

A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation–Positive Solid Tumors

Mark W. Kieran, Birgit Geoerger, Ira J. Dunkel, Alberto Broniscer, Darren Hargrave, Pooja Hingorani, Isabelle Aerts, Anne-Isabelle Bertozzi, Kenneth J. Cohen, Trent R. Hummel, Violet Shen, Eric Bouffet, Christine A. Pratilas, Andrew D.J. Pearson, Lillian Tseng, Noelia Nebot, Steven Green, Mark W. Russo and James A. Whitlock

Clin Cancer Res December 15 2019 25 (24) 7294-7302; DOI:10.1158/1078-0432.CCR-17-3572
Clinical Trials: Targeted Therapy

Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

Darren R. Hargrave, Eric Bouffet, Uri Tabori, Alberto Broniscer, Kenneth J. Cohen, Jordan R. Hansford, Birgit Geoerger, Pooja Hingorani, Ira J. Dunkel, Mark W. Russo, Lillian Tseng, Kohinoor Dasgupta, Eduard Gasal, James A. Whitlock and Mark W. Kieran

Clin Cancer Res December 15 2019 25 (24) 7303-7311; DOI:10.1158/1078-0432.CCR-19-2177
Clinical Trials: Targeted Therapy | AuthorChoice

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo, Federica D'Incà, Claudio Dazzi, Antonio Chella, Angelo Delmonte, Laura Bonanno, Diana Giannarelli, Diego Luigi Cortinovis, Filippo de Marinis, Gloria Borra, Alessandro Morabito, Cesare Gridelli, Domenico Galetta, Fausto Barbieri, Francesco Grossi, Enrica Capelletto, Gabriele Minuti, Francesca Mazzoni, Claudio Verusio, Emilio Bria, Greta Alì, Rossella Bruno, Agnese Proietti, Gabriella Fontanini, Lucio Crinò and Federico Cappuzzo

Clin Cancer Res December 15 2019 25 (24) 7312-7319; DOI:10.1158/1078-0432.CCR-19-0994
Clinical Trials: Targeted Therapy

Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies

Hiroto Inaba, John C. Panetta, Stanley B. Pounds, Lei Wang, Lie Li, Fariba Navid, Sara M. Federico, Eric D. Eisenmann, Aksana Vasilyeva, Yong-Dong Wang, Sheila Shurtleff, Ching-Hon Pui, Tanja A. Gruber, Raul C. Ribeiro, Jeffrey E. Rubnitz and Sharyn D. Baker

Clin Cancer Res December 15 2019 25 (24) 7320-7330; DOI:10.1158/1078-0432.CCR-19-0470
Clinical Trials: Targeted Therapy

Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid Tumors

Timothy A. Yap, Jane N. Winter, Lisa Giulino-Roth, Jemma Longley, Juanita Lopez, Jean-Marie Michot, John P. Leonard, Vincent Ribrag, Michael T. McCabe, Caretha L. Creasy, Melissa Stern, Teodora Pene Dumitrescu, Xiaowei Wang, Steve Frey, Jennifer Carver, Thierry Horner, Choon Oh, Ahmed Khaled, Arindam Dhar and Peter W.M. Johnson

Clin Cancer Res December 15 2019 25 (24) 7331-7339; DOI:10.1158/1078-0432.CCR-18-4121

Clinical Trials: Immunotherapy

Clinical Trials: Immunotherapy

T-Cell Receptor Stimulation Enhances the Expansion and Function of CD19 Chimeric Antigen Receptor–Expressing T Cells

Natalia Lapteva, Margaret Gilbert, Iulia Diaconu, Lisa A. Rollins, Mina Al-Sabbagh, Swati Naik, Robert A. Krance, Tamara Tripic, Manasa Hiregange, Darshana Raghavan, Olga Dakhova, Rayne H. Rouce, Hao Liu, Bilal Omer, Barbara Savoldo, Gianpietro Dotti, Conrad Russel Cruz, Keli Sharpe, Melissa Gates, Aaron Orozco, April Durett, Elizabeth Pacheco, Adrian P. Gee, Carlos A. Ramos, Helen E. Heslop, Malcolm K. Brenner and Cliona M. Rooney

Clin Cancer Res December 15 2019 25 (24) 7340-7350; DOI:10.1158/1078-0432.CCR-18-3199
Clinical Trials: Immunotherapy | AuthorChoice

Guadecitabine Plus Ipilimumab in Unresectable Melanoma: The NIBIT-M4 Clinical Trial

Anna Maria Di Giacomo, Alessia Covre, Francesca Finotello, Dietmar Rieder, Riccardo Danielli, Luca Sigalotti, Diana Giannarelli, Florent Petitprez, Laetitia Lacroix, Monica Valente, Ornella Cutaia, Carolina Fazio, Giovanni Amato, Andrea Lazzeri, Santa Monterisi, Clelia Miracco, Sandra Coral, Andrea Anichini, Christoph Bock, Amelie Nemc, Aram Oganesian, James Lowder, Mohammad Azab, Wolf H. Fridman, Catherine Sautès-Fridman, Zlatko Trajanoski and Michele Maio

Clin Cancer Res December 15 2019 25 (24) 7351-7362; DOI:10.1158/1078-0432.CCR-19-1335
Clinical Trials: Immunotherapy

A Single-Arm, Multicenter, Phase II Study of Camrelizumab in Relapsed or Refractory Classical Hodgkin Lymphoma

Yuqin Song, Jianqiu Wu, Xinchuan Chen, Tongyu Lin, Junning Cao, Yanyan Liu, Yaozhong Zhao, Jie Jin, Haiwen Huang, Jianda Hu, Jun Luo, Liling Zhang, Hongwei Xue, Qingyuan Zhang, Weiwei Wang, Chunxia Chen, Jifeng Feng and Jun Zhu

Clin Cancer Res December 15 2019 25 (24) 7363-7369; DOI:10.1158/1078-0432.CCR-19-1680

Precision Medicine and Imaging

Precision Medicine and Imaging

Analysis of Biomarkers and Association With Clinical Outcomes in Patients With Differentiated Thyroid Cancer: Subanalysis of the Sorafenib Phase III DECISION Trial

Marcia S. Brose, Martin Schlumbeger, Michael Jeffers, Christian Kappeler, Gerold Meinhardt and Carol E.A. Peña

Clin Cancer Res December 15 2019 25 (24) 7370-7380; DOI:10.1158/1078-0432.CCR-18-3439
Precision Medicine and Imaging

Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib

Gary A. Ulaner, Cristina Saura, Sarina A. Piha-Paul, Ingrid Mayer, David Quinn, Komal Jhaveri, Ben Stone, Seta Shahin, Grace Mann, Melanie Dujka, Richard Bryce, Funda Meric-Bernstam, David B. Solit and David M. Hyman

Clin Cancer Res December 15 2019 25 (24) 7381-7387; DOI:10.1158/1078-0432.CCR-19-1658
Precision Medicine and Imaging

Long-Term Survival Analysis of Adjuvant Chemotherapy with or without Trastuzumab in Patients with T1, Node-Negative HER2-Positive Breast Cancer

Xuexin He, Jiali Ji, Mei Tian, Francisco J. Esteva, Gabriel N. Hortobagyi and Sai-Ching Jim Yeung

Clin Cancer Res December 15 2019 25 (24) 7388-7395; DOI:10.1158/1078-0432.CCR-19-0463
Precision Medicine and Imaging

Discovery, Validation, and Application of Novel Methylated DNA Markers for Detection of Esophageal Cancer in Plasma

Yi Qin, Chung W. Wu, William R. Taylor, Tarek Sawas, Kelli N. Burger, Douglas W. Mahoney, Zhifu Sun, Tracy C. Yab, Graham P. Lidgard, Hatim T. Allawi, Navtej S. Buttar, Thomas C. Smyrk, Prasad G. Iyer, David A. Katzka, David A. Ahlquist and John B. Kisiel

Clin Cancer Res December 15 2019 25 (24) 7396-7404; DOI:10.1158/1078-0432.CCR-19-0740
Precision Medicine and Imaging

Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients

Simon Laban, Dominik S. Gangkofner, Dana Holzinger, Lea Schroeder, Stefan B. Eichmüller, Inka Zörnig, Dirk Jäger, Gunnar Wichmann, Andreas Dietz, Martina A. Broglie, Christel C. Herold-Mende, Gerhard Dyckhoff, Paolo Boscolo-Rizzo, Jasmin Ezić, Ralf Marienfeld, Peter Möller, Johann M. Kraus, Gunnar Völkel, Hans A. Kestler, Cornelia Brunner, Patrick J. Schuler, Marlene C. Wigand, Marie-Nicole Theodoraki, Johannes Doescher, Thomas K. Hoffmann, Michael Pawlita, Tim Waterboer and Julia Butt

Clin Cancer Res December 15 2019 25 (24) 7405-7412; DOI:10.1158/1078-0432.CCR-19-1490
Precision Medicine and Imaging

Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer

Li Liu, Xue Bai, Jian Wang, Xin-Ran Tang, De-Hua Wu, Sha-Sha Du, Xiu-Ju Du, Yao-Wei Zhang, Hong-Bo Zhu, Yuan Fang, Ze-Qin Guo, Qin Zeng, Xue-Jun Guo, Zhu Liu and Zhong-Yi Dong

Clin Cancer Res December 15 2019 25 (24) 7413-7423; DOI:10.1158/1078-0432.CCR-19-0558
Precision Medicine and Imaging | AuthorChoice

Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma

Rohit Thakur, Jonathan P. Laye, Martin Lauss, Joey Mark S. Diaz, Sally Jane O'Shea, Joanna Poźniak, Anastasia Filia, Mark Harland, Joanne Gascoyne, Juliette A. Randerson-Moor, May Chan, Tracey Mell, Göran Jönsson, D. Timothy Bishop, Julia Newton-Bishop, Jennifer H. Barrett and Jérémie Nsengimana

Clin Cancer Res December 15 2019 25 (24) 7424-7435; DOI:10.1158/1078-0432.CCR-18-3659
Precision Medicine and Imaging

Longitudinal Photoacoustic Imaging of the Pharmacodynamic Effect of Vascular Targeted Therapy on Tumors

S. Peter Johnson, Olumide Ogunlade, Mark F. Lythgoe, Paul Beard and R. Barbara Pedley

Clin Cancer Res December 15 2019 25 (24) 7436-7447; DOI:10.1158/1078-0432.CCR-19-0360
Precision Medicine and Imaging

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

Wolfgang P. Fendler, Manuel Weber, Amir Iravani, Michael S. Hofman, Jérémie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J. Small, Matthew R. Smith, Paola M. Perez, Thomas A. Hope, Isabel Rauscher, Anil Londhe, Angela Lopez-Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber and Boris Hadaschik

Clin Cancer Res December 15 2019 25 (24) 7448-7454; DOI:10.1158/1078-0432.CCR-19-1050
Precision Medicine and Imaging | AuthorChoice

Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm

Sebastian R. van der Voort, Fatih Incekara, Maarten M.J. Wijnenga, Georgios Kapas, Mayke Gardeniers, Joost W. Schouten, Martijn P.A. Starmans, Rishie Nandoe Tewarie, Geert J. Lycklama, Pim J. French, Hendrikus J. Dubbink, Martin J. van den Bent, Arnaud J.P.E. Vincent, Wiro J. Niessen, Stefan Klein and Marion Smits

Clin Cancer Res December 15 2019 25 (24) 7455-7462; DOI:10.1158/1078-0432.CCR-19-1127
Precision Medicine and Imaging

ImmunoPET, [⁶⁴Cu]Cu-DOTA-Anti-CD33 PET-CT, Imaging of an AML Xenograft Model

Sargur Madabushi Srideshikan, Jamison Brooks, Darren Zuro, Bijender Kumar, James Sanchez, Liliana Echavarria Parra, Marvin Orellana, Paresh Vishwasrao, Indu Nair, Junie Chea, Kofi Poku, Nicole Bowles, Aaron Miller, Todd Ebner, Justin Molnar, Joseph Rosenthal, Daniel A. Vallera, Jeffrey Y.C. Wong, Anthony S. Stein, David Colcher, John E. Shively, Paul J. Yazaki and Susanta K. Hui

Clin Cancer Res December 15 2019 25 (24) 7463-7474; DOI:10.1158/1078-0432.CCR-19-1106

Translational Cancer Mechanisms and Therapy

Translational Cancer Mechanisms and Therapy

Analysis of Tumor Genomic Pathway Alterations Using Broad-Panel Next-Generation Sequencing in Surgically Resected Lung Adenocarcinoma

Jian Zhou, Francisco Sanchez-Vega, Raul Caso, Kay See Tan, Whitney S. Brandt, Gregory D. Jones, Shi Yan, Prasad S. Adusumilli, Matthew Bott, James Huang, James M. Isbell, Smita Sihag, Daniela Molena, Valerie W. Rusch, Walid K. Chatila, Natasha Rekhtman, Fan Yang, Marc Ladanyi, David B. Solit, Michael F. Berger, Nikolaus Schultz and David R. Jones

Clin Cancer Res December 15 2019 25 (24) 7475-7484; DOI:10.1158/1078-0432.CCR-19-1651
Translational Cancer Mechanisms and Therapy | AuthorChoice

Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors

Mariana Ferreira Leal, Ben P. Haynes, Eugene Schuster, Belinda Yeo, Maria Afentakis, Lila Zabaglo, Vera Martins, Richard Buus, Andrew Dodson, Maggie C.U. Cheang, Ian E. Smith, Lesley-Ann Martin and Mitch Dowsett

Clin Cancer Res December 15 2019 25 (24) 7485-7496; DOI:10.1158/1078-0432.CCR-19-1129
Translational Cancer Mechanisms and Therapy

Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance)

Chen Yuan, Kaori Sato, Bruce W. Hollis, Sui Zhang, Donna Niedzwiecki, Fang-Shu Ou, I-Wen Chang, Bert H. O'Neil, Federico Innocenti, Heinz-Josef Lenz, Charles D. Blanke, Richard M. Goldberg, Alan P. Venook, Robert J. Mayer, Charles S. Fuchs, Jeffrey A. Meyerhardt and Kimmie Ng

Clin Cancer Res December 15 2019 25 (24) 7497-7505; DOI:10.1158/1078-0432.CCR-19-0877
Translational Cancer Mechanisms and Therapy

Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors

Ashwini Balakrishnan, Anusha Rajan, Alexander I. Salter, Paula L. Kosasih, Qian Wu, Jenna Voutsinas, Michael C. Jensen, Andreas Plückthun and Stanley R. Riddell

Clin Cancer Res December 15 2019 25 (24) 7506-7516; DOI:10.1158/1078-0432.CCR-19-1479
Translational Cancer Mechanisms and Therapy | AuthorChoice

Germline BRCA-Associated Endometrial Carcinoma Is a Distinct Clinicopathologic Entity

Marthe M. de Jonge, Lauren L. Ritterhouse, Cornelis D. de Kroon, Maaike P.G. Vreeswijk, Jeremy P. Segal, Rutika Puranik; for the HEBON Group, Harry Hollema, Matti A. Rookus, Christi J. van Asperen, Flora E. van Leeuwen, Vincent T.H.B.M. Smit, Brooke E. Howitt and Tjalling Bosse

Clin Cancer Res December 15 2019 25 (24) 7517-7526; DOI:10.1158/1078-0432.CCR-19-0848
Translational Cancer Mechanisms and Therapy | AuthorChoice

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL–Induced B-Cell Acute Lymphoblastic Leukemia

Linyu Yang, Qiang Qiu, Minghai Tang, Fang Wang, Yuyao Yi, Dongni Yi, Zhuang Yang, Zejiang Zhu, Shoujun Zheng, Jianhong Yang, Heying Pei, Li Zheng, Yong Chen, Liping Gou, Liya Luo, Xing Deng, Haoyu Ye, Yiguo Hu, Ting Niu and Lijuan Chen

Clin Cancer Res December 15 2019 25 (24) 7527-7539; DOI:10.1158/1078-0432.CCR-19-0516
Translational Cancer Mechanisms and Therapy | AuthorChoice

Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia

Beatrice Del Papa, Stefano Baldoni, Erica Dorillo, Filomena De Falco, Chiara Rompietti, Debora Cecchini, Maria Grazia Cantelmi, Daniele Sorcini, Manuel Nogarotto, Francesco Maria Adamo, Federica Mezzasoma, Estevão Carlos Silva Barcelos, Elisa Albi, Roberta Iacucci Ostini, Ambra Di Tommaso, Andrea Marra, Guido Montanaro, Maria Paola Martelli, Franca Falzetti, Mauro Di Ianni, Emanuela Rosati and Paolo Sportoletti

Clin Cancer Res December 15 2019 25 (24) 7540-7553; DOI:10.1158/1078-0432.CCR-19-1009
Translational Cancer Mechanisms and Therapy

Interleukin-15 Enhances Anti-GD2 Antibody-Mediated Cytotoxicity in an Orthotopic PDX Model of Neuroblastoma

Rosa Nguyen, Ardiana Moustaki, Jacqueline L. Norrie, Shantel Brown, Walter J. Akers, Abbas Shirinifard and Michael A. Dyer

Clin Cancer Res December 15 2019 25 (24) 7554-7564; DOI:10.1158/1078-0432.CCR-19-1045
Translational Cancer Mechanisms and Therapy

Combination of PPARγ Agonist Pioglitazone and Trabectedin Induce Adipocyte Differentiation to Overcome Trabectedin Resistance in Myxoid Liposarcomas

Roberta Frapolli, Ezia Bello, Marianna Ponzo, Ilaria Craparotta, Laura Mannarino, Sara Ballabio, Sergio Marchini, Laura Carrassa, Paolo Ubezio, Luca Porcu, Silvia Brich, Roberta Sanfilippo, Paolo Giovanni Casali, Alessandro Gronchi, Silvana Pilotti and Maurizio D'Incalci

Clin Cancer Res December 15 2019 25 (24) 7565-7575; DOI:10.1158/1078-0432.CCR-19-0976
Translational Cancer Mechanisms and Therapy

Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses

Mauricio S. Caetano, Ahmed I. Younes, Hampartsoum B. Barsoumian, Michael Quigley, Hari Menon, Chan Gao, Thomas Spires, Timothy P. Reilly, Alexandra P. Cadena, Taylor R. Cushman, Jonathan E. Schoenhals, Ailin Li, Quynh-Nhu Nguyen, Maria Angelica Cortez and James W. Welsh

Clin Cancer Res December 15 2019 25 (24) 7576-7584; DOI:10.1158/1078-0432.CCR-19-0795
Translational Cancer Mechanisms and Therapy

Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma

Kenjiro Namikawa, Phyu P. Aung, Denái R. Milton, Michael T. Tetzlaff, Carlos A. Torres-Cabala, Jonathan L. Curry, Priyadharsini Nagarajan, Doina Ivan, Merrick Ross, Jeffrey E. Gershenwald and Victor G. Prieto

Clin Cancer Res December 15 2019 25 (24) 7585-7593; DOI:10.1158/1078-0432.CCR-19-1194
Translational Cancer Mechanisms and Therapy

Mechanisms and Antitumor Activity of a Binary EGFR/DNA–Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide

Zeinab Sharifi, Bassam Abdulkarim, Brian Meehan, Janusz Rak, Paul Daniel, Julie Schmitt, Nidia Lauzon, Kolja Eppert, Heather M. Duncan, Kevin Petrecca, Marie-Christine Guiot, Bertrand Jean-Claude and Siham Sabri

Clin Cancer Res December 15 2019 25 (24) 7594-7608; DOI:10.1158/1078-0432.CCR-19-0955

Letter to the Editor

Letter to the Editor

Exercise Window Trial in Newly Diagnosed Breast Cancer–Letter

Andrew H. Sims, Melanie Leggate and Anna Campbell

Clin Cancer Res December 15 2019 25 (24) 7609-7610; DOI:10.1158/1078-0432.CCR-19-2571

Correction

Correction | Free Article

Correction: Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability

Jianfeng Zhou, Qinglei Gao, Gang Chen, Xiaoyuan Huang, Yunping Lu, Kanyan Li, Daxing Xie, Liang Zhuang, Jingniu Deng and Ding Ma

Clin Cancer Res December 15 2019 25 (24) 7611-7611; DOI:10.1158/1078-0432.CCR-19-3370

Main menu

User menu

Search

Table of Contents

Highlights

CCR Translations

CCR Drug Updates

Perspectives

Clinical Trials: Targeted Therapy

Clinical Trials: Immunotherapy

Precision Medicine and Imaging

Translational Cancer Mechanisms and Therapy

Letter to the Editor

Correction

Issue Highlights

Jump to

Articles

Info for

About Clinical Cancer Research